Cleared Traditional

HEMOSIL D-DIMER

K073042 · Instrumentation Laboratory · Hematology
Jul 2008
Decision
276d
Days
Class 2
Risk

About This 510(k) Submission

K073042 is an FDA 510(k) clearance for the HEMOSIL D-DIMER, a Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (Class II — Special Controls, product code DAP), submitted by Instrumentation Laboratory (Lexington, US). The FDA issued a Cleared decision on July 31, 2008, 276 days after receiving the submission on October 29, 2007. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7320.

Submission Details

510(k) Number K073042 FDA.gov
FDA Decision Cleared SESE
Date Received October 29, 2007
Decision Date July 31, 2008
Days to Decision 276 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code DAP — Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7320

Similar Devices — DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 56
HemosIL D-Dimer HS 500
K172903 · Instrumentation Laboratory CO · Nov 2017
STA? - Liatest? D-Di
K162227 · Diagnostica-Stago · Dec 2016
HemosIL D-Dimer HS
K160885 · Instrumentation Laboratory CO · Oct 2016
HemosIL D-Dimer HS
K151534 · Instrumentation Laboratory CO · Jul 2015
STA LIATEST D-DI
K141144 · Diagnostica-Stago · Sep 2014
VIDAS D-DIMER EXCLUSION II (DEX2)
K112818 · bioMerieux, Inc. · Jul 2012